China Resources Medical Holdings 配当と自社株買い
配当金 基準チェック /36
China Resources Medical Holdings配当を支払う会社であり、現在の利回りは2.78%で、収益によって十分にカバーされています。
主要情報
2.8%
配当利回り
n/a
バイバック利回り
| 総株主利回り | n/a |
| 将来の配当利回り | 6.2% |
| 配当成長 | 12.5% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | HK$0.111 |
| 配当性向 | 47% |
最近の配当と自社株買いの更新
Recent updates
Returns At China Resources Medical Holdings (HKG:1515) Appear To Be Weighed Down
Nov 14
Market Participants Recognise China Resources Medical Holdings Company Limited's (HKG:1515) Earnings Pushing Shares 34% Higher
Oct 02We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings
May 06China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Apr 26Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price
Mar 09Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?
Nov 29China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall
Oct 19Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Aug 30Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?
Aug 26China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet
Jun 30China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
May 12Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)
Apr 03Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Feb 21China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital
Jan 10We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Nov 30Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?
Oct 18China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends
Sep 21Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?
Jul 13Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Jun 24China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12
Jun 03China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12
Apr 27We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease
Apr 22Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%
Mar 30Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?
Jan 27China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jan 03China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around
Nov 19Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?
Oct 26An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued
Sep 20Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly
Sep 06China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively
Aug 17Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher
Jun 21China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate
Jun 09Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality
May 03China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?
Apr 22We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt
Mar 27決済の安定と成長
配当データの取得
安定した配当: 1515の配当金支払いは、過去10年間 変動性 が高かった。
増加する配当: 1515の配当金は過去10年間にわたって増加しています。
配当利回り対市場
| China Resources Medical Holdings 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (1515) | 2.8% |
| 市場下位25% (HK) | 3.3% |
| 市場トップ25% (HK) | 8.1% |
| 業界平均 (Healthcare) | 4.0% |
| アナリスト予想 (1515) (最長3年) | 6.2% |
注目すべき配当: 1515の配当金 ( 2.78% ) はHong Kong市場の配当金支払者の下位 25% ( 3.3% ) と比べると目立ったものではありません。
高配当: 1515の配当金 ( 2.78% ) はHong Kong市場の配当金支払者の上位 25% ( 8.09% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: 1515の 配当性向 ( 47.3% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: 1515は低い 現金配当性向 ( 20.9% ) であるため、配当金の支払いはキャッシュフローによって十分にカバーされています。